Profitability Ratios
| Ratio |
Value |
| GP Margin |
71.9% |
| EBIT Margin |
17.5% |
| EBITDA Margin |
28.5% |
| Operating Margin |
23.5% |
| Pretax Margin |
12.6% |
| Cont. Ops Margin |
12.7% |
| Net Margin |
12.6% |
| Bottom Line Margin |
12.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.17 |
| Quick Ratio |
0.92 |
| Solvency Ratio |
0.120 |
| Cash Ratio |
0.02 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
5.37 |
| PEG Ratio |
0.02 |
| Forward PEG |
0.02 |
| Price/Book |
0.49 |
| Price/Sales |
0.68 |
| Price/FCF |
4.39 |
| Price/Op Cash Flow |
3.38 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2983 |
| Debt/Equity |
0.7216 |
| Debt/Capital |
0.4192 |
| Long-Term Debt/Capital |
0.3913 |
| Financial Leverage |
2.42 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
43.85 |
| Operating Cash Flow Ratio |
0.296 |
| Operating Cash Flow/Sales |
20.0% |
| Free Cash Flow/Operating Cash Flow |
77.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.81 |
| Interest Coverage |
4.8327 |
| Short-Term Operating Cash Flow Coverage |
1.83 |
| Operating Cash Flow Coverage |
0.20 |
| Capital Expenditure Coverage |
4.38 |
| Dividend + Capital Expenditure Coverage |
1.03 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
118.4410% |
| Dividend Yield |
22.0550% |
| Dividend Yield % |
22.0550% |
| Dividend Per Share |
1.6794 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
11.23 |
| EPS |
1.418 |
| Debt/Share |
11.7832 |
| Cash/Share |
3.62 |
| Book Value/Share |
15.62 |
| Tangible BV/Share |
-6.26 |
| Equity/Share |
15.57 |
| Operating Cash Flow/Share |
2.250 |
| Capital Expenditure/Share |
0.514 |
| FCF/Share |
1.736 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.001 |
| Earnings Before Tax/EBIT |
0.537 |
| Price/Fair Value |
0.49 |
| Debt/Market Cap |
0.3689 |
| Effective Tax Rate |
-0.3% |
| Enterprise Value Multiple |
12.97 |
PFE.BA - Pfizer Inc.